Orexo and Abera Partner to Develop Nasal Powder Vaccines
The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.
https://www.pharmtech.com/view..../orexo-abera-partner
Discover the world at Altruu, The Discovery Engine